| Bioactivity | DCN1-UBC12-IN-4 (compound 5p) is an inhibitor of DCN1-UBC12, with an IC50 greater than 10000 nM, and it exhibits anti-tumor activity[1]. | ||||||||||||
| CAS | 26028-65-9 | ||||||||||||
| Formula | C8H6ClN3S | ||||||||||||
| Molar Mass | 211.68 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Wenjuan Zhou, et al. Development of phenyltriazole thiol-based derivatives as highly potent inhibitors of DCN1-UBC12 interaction. Eur J Med Chem. 2021 May 5:217:113326. |
DCN1-UBC12-IN-4
CAS: 26028-65-9 F: C8H6ClN3S W: 211.68
DCN1-UBC12-IN-4 (compound 5p) is an inhibitor of DCN1-UBC12, with an IC50 greater than 10000 nM, and it exhibits anti-tu
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.